Glucans: A Therapeutic Alternative for Sepsis Treatment

IF 3.5 3区 医学 Q2 IMMUNOLOGY Journal of Immunology Research Pub Date : 2024-05-27 DOI:10.1155/2024/6876247
Jesse P. M. Viana, Fernanda F. Costa, Tatielle G. Dias, Priscila M. Mendes, Gabriel B. Copeland, Willian S. Nascimento, Sofia S. N. Mendes, Isabella F. S. Figueiredo, Elizabeth S. Fernandes, Anamelia L. Bocca, Márcia C. G. Maciel
{"title":"Glucans: A Therapeutic Alternative for Sepsis Treatment","authors":"Jesse P. M. Viana, Fernanda F. Costa, Tatielle G. Dias, Priscila M. Mendes, Gabriel B. Copeland, Willian S. Nascimento, Sofia S. N. Mendes, Isabella F. S. Figueiredo, Elizabeth S. Fernandes, Anamelia L. Bocca, Márcia C. G. Maciel","doi":"10.1155/2024/6876247","DOIUrl":null,"url":null,"abstract":"Sepsis treatment is a challenging condition due to its complexity, which involves host inflammatory responses to a severe and potentially fatal infection, associated with organ dysfunction. The aim of this study was to analyze the scientific literature on the immunomodulatory effects of glucans in a murine model of systemic infection induced by cecal ligation and puncture. This study comprises an integrative literature review based on systematic steps, with searches carried out in the PubMed, ScienceDirect, Scopus, Web of Science, and Embase databases. In most studies, the main type of glucan investigated was <i>β</i>-glucan, at 50 mg/kg, and a reduction of inflammatory responses was identified, minimizing the occurrence of tissue damage leading to increased animal survival. Based on the data obtained and discussed in this review, glucans represent a promising biotechnological alternative to modulate the immune response and could potentially be used in the clinical management of septic individuals.","PeriodicalId":15952,"journal":{"name":"Journal of Immunology Research","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2024/6876247","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Sepsis treatment is a challenging condition due to its complexity, which involves host inflammatory responses to a severe and potentially fatal infection, associated with organ dysfunction. The aim of this study was to analyze the scientific literature on the immunomodulatory effects of glucans in a murine model of systemic infection induced by cecal ligation and puncture. This study comprises an integrative literature review based on systematic steps, with searches carried out in the PubMed, ScienceDirect, Scopus, Web of Science, and Embase databases. In most studies, the main type of glucan investigated was β-glucan, at 50 mg/kg, and a reduction of inflammatory responses was identified, minimizing the occurrence of tissue damage leading to increased animal survival. Based on the data obtained and discussed in this review, glucans represent a promising biotechnological alternative to modulate the immune response and could potentially be used in the clinical management of septic individuals.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
葡聚糖:败血症治疗的替代疗法
败血症治疗因其复杂性而具有挑战性,它涉及宿主对严重且可能致命的感染的炎症反应,并伴有器官功能障碍。本研究旨在分析有关葡聚糖在通过盲肠结扎和穿刺诱导的小鼠全身感染模型中的免疫调节作用的科学文献。本研究包括基于系统步骤的综合文献综述,在 PubMed、ScienceDirect、Scopus、Web of Science 和 Embase 数据库中进行了检索。在大多数研究中,调查的主要葡聚糖类型是 β-葡聚糖,剂量为 50 毫克/千克,结果发现它能减轻炎症反应,最大限度地减少组织损伤的发生,从而提高动物的存活率。根据本综述所获得和讨论的数据,葡聚糖是一种很有前景的调节免疫反应的生物技术替代品,有可能用于败血症患者的临床治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.90
自引率
2.40%
发文量
423
审稿时长
15 weeks
期刊介绍: Journal of Immunology Research is a peer-reviewed, Open Access journal that provides a platform for scientists and clinicians working in different areas of immunology and therapy. The journal publishes research articles, review articles, as well as clinical studies related to classical immunology, molecular immunology, clinical immunology, cancer immunology, transplantation immunology, immune pathology, immunodeficiency, autoimmune diseases, immune disorders, and immunotherapy.
期刊最新文献
The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics. Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3. Promoting Articular Cartilage Regeneration through Microenvironmental Regulation. Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis. Breastfeeding and Neonatal Age Influence Neutrophil-Driven Ontogeny of Blood Cell Populations in the First Week of Human Life.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1